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Abstract 
On average, each Ventilator-Associated Event (VAE) is anticipated to increase the length 
of stay in the Intensive Care Unit (ICU), resulting in potential adverse events and cost to the 
organization. The Center for Disease Control (CDC) defines VAE as the increase of daily 
minimum positive end-expiratory pressure (PEEP) and fraction of inspired oxygen (FiO2) 
values, after a baseline period of patient stability or  improvement on the ventilator (CDC, 2018). 
Standard endotracheal tube designs have led to the incidence of VAE because of the 
accumulation of subglottic secretions in the trachea. Untreated VAE can later result in Ventilator 
Associated Pneumonia (VAP). A clinical nurse leader (CNL) focuses on all clinical elements to 
reduce subglottic secretions by leading a practice improvement project in the Level II Trauma 
Center of a mid-sized suburban community hospital with assistance of a multidisciplinary team 
called Prevent VAE Team. The multidisciplinary team will assess the incidence of VAE and aim 
to evaluate interventions that increase adherence to evidence-based practices to reduce VAP. A 
retrospective case review reveals that the pattern and prevalence of VAE is primarily related to 
the presence of the standard endotracheal tube, which causes accumulation of subglottic 
secretions in the trachea, on patients hospitalized in the ICU setting. Based on the observed 
variation in the ICU microsystem, placing subglottic endotracheal tubes (SETT) into the 
operating room (OR) and emergency medical system (EMS) settings appears to address the root 
cause of excessive VAE in the ICU setting. Providing front line staff feedback, debriefing, and 
coaching brought awareness to achieve the long-term goal of reducing VAE to zero. Over a 6-
month period, this improvement project resulted in reduction of VAE from 31 ICU events (six 
attributed to trauma patients) to three ICU events (0 attributed to trauma patients). The 
improvement project supports the creation of a culture of safety, continuous improvement, 
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evidence-based practice, and cost avoidance in the ICU. The organizational commitment to this 
project will extend over a 1-year period. 
Keywords:  Ventilator-Associated Event, Intensive Care Unit, positive end-expiratory 
pressure, fraction of inspired oxygen, Ventilator Associated Pneumonia, Ventilator Associated 
Pneumonia, subglottic endotracheal tube. 
  
IMPROVE EFFECTIVENESS TO REDUCE VAE 5 
 
Introduction 
Increased mortality projections have been associated with increase Intensive Care 
Unit (ICU) length of stay (Bekaert, 2011). The problem is that on average, a diagnosis 
including ventilator-associated event (VAE) is anticipated to increase ICU length of stay 
by a mean of 4.3 days with a 95% confidence interval, 1.5 – 7.0 day: P<.001 (Vincent, 
2012).  
The Center for Disease Control (CDC) defines VAE as the increase of daily 
minimum positive end-expiratory pressure (PEEP) and fraction of inspired oxygen (FiO2) 
values, after a baseline period of patient stability or  improvement on the ventilator for 
over 48 hours (CDC, 2018). Daily min FiO2 has to increase >= 0.20 (20 points) for >=2 
days. PEEP value is defined by a daily min PEEP increase >= 3 cm H2O maintained for 
>=2 days (NHSN, 2017).  
Untreated VAE can later result in Ventilator Associated Pneumonia (VAP). For a VAP to 
occur, the VAE patient has to have a spike in temperature and increase of white blood cells 
(WBC). Fever is defined as a body temperature of >100.4 ºF or >38 ºC. White blood cell 
(WBC) is defined as increase of WBC >12,000 cells/mm³ or <4,000 cells/mm³.  All 
ventilated patients with early identification of pneumonia will start new antimicrobial 
agent(s) and will continue the treatment for >= 4 days (NHSN, 2017).  These 
differentiation factors determine whether a patient has VAE or a VAP.  
Standard endotracheal tube designs have led to the incidence of VAE because of 
the accumulation of subglottic secretions in the trachea. With the accumulation of 
secretions, the patient is at risk to develop a biofilm that will lead to the growth of 
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microorganisms. Reduction of subglottic secretions will eliminate the bacterial -rich 
environment, which generates VAP (Muscedere et al., 2011). The diagnosis of VAP is 
normally seen in the electronic health record, so for the emphasis of this project will refer to 
VAP as the acute diagnosis derived from adverse ventilator associated event (National Health 
Safety Network [NHSN], 2017).   
Available knowledge 
In 2013, NHSN through a multidisciplinary collaborative integrated by Critical Care 
Societies, American College of Chest Physicians, American Thoracic Society, American 
Association for Respiratory Care, Association of Professionals in Infection Control and 
Epidemiology, Council of State and Territorial Epidemiologists, Healthcare Infection Control 
Practices Advisory Committee’s Surveillance Working Group, Infectious Diseases Society of 
America, and Society for Healthcare Epidemiology of America, develop objective criteria for 
determining VAE as a hospital-acquired infections (NHSN, 2017).  The VAE Surveillance 
Algorithm (Appendix A) objectively demonstrate a standardized measure to consistently define 
VAE.  
Over 300,000 patients per year in the United States will incur medical conditions that 
warrant mechanical ventilation (Cason, Tyner, Saunders, & Broome, 2007). Ventilator-
associated events are preventable. As CNLs, it is our mission to improve patient outcomes by 
ensuring the safe delivery of VAE prevention bundles. The goal of this quality improvement 
project is to reduce subglottic secretions, which produce biofilm on the endotracheal tubes that 
provide the bacterial-rich environment, which generates VAE.  
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Problem description 
With the accumulation of secretions, the patient is at risk to develop a biofilm that will 
lead to the growth of microorganisms. Reduction of subglottic secretions will eliminate the 
bacterial-rich environment, which generates VAP (Muscedere et al., 2011). During a prospective 
meta-analyses cohort study with randomized controlled trials, a multicenter European study 
shows VAE to be the most common Hospital Associated Condition (HAC) in the ICU, with a 
mortality associated of 24% to 71%. The study shows that the most common causative 
organisms are Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacteriaceae. These 
organisms affect 9% to 24% of ventilated patients (Vincent, 2012).  
The most costly HAC that affects the local Level II Trauma Center is VAE. The 
incidence of VAE that drew the trauma department’s attention was that 21 VAE events has been 
attributed to ventilated trauma patients in 2017. In the first six months of 2018, 6 events are 
identified as HAC (CDM, 2018).  
In a comprehensive microsystem assessment, VAE identification continues to be the 
highest HAC incidence of the Trauma Quality Improvement Program’s (TQIP) report. Over the 
last year, the incidence of VAE has increased to be the number one HAC in the Level II Trauma 
Center’s ICU. From January to June 2018, there has been six VAE cases identified. Although the 
number may not seem daunting, that increased mortality associated with VAE, is a stimulus for 
action for the multidisciplinary team, called Prevent VAE Team (TQIP, 2018). 
The 2017 American College of Surgeons (ACS) verification report identifies that the 
Trauma department coordination with the medical center’s Quality department is in need to 
improve quality, at the systems-level by reducing VAE as a HAC (ACS, 2017).  As a risk 
anticipator, the CNL leading this project guide the system level change in the ICU micro-system.  
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The CNL from the Trauma department operates in the mesosystem and works as a patient 
advocate addressing VAE at the point of care. Coordination of the high-functioning 
multidisciplinary team requires focused understanding of the expertise that each team member 
brings to solve this multifactorial problem of eliminating VAE in the Level II Trauma Medical 
Center.   
Knowledge 
In the Level II Trauma Center, 96,000 patients receive treatment in 2017. 2,400 of these 
patients are Trauma. Out of the 96,000 patients, 117 are attributed to have a diagnosis of VAP.  
Of those 117 VAP patients, 93 are medical and 24 trauma patients. The cost to the patient is an 
increased risk for morbidity and mortality associated with the HAC. After examining the first 
six-months of 2018, there are six patients that developed VAP (CDM, 2018).  Despite the slight 
decrease of VAP in 2018, the facility is still far from their goal of aim to zero VAP by 2019.  
Our goal is to drive the prevalence to zero within the year.  
Evidence-based practice shows that the development of biofilm that travels from the 
endotracheal tube into the lungs is identified as the source that leads to VAP. The biofilm is the 
reservoir for the bacterial to grow, which is encapsulated and makes treatment more complicated 
(Levasseur, 2001).    
Subglottic Endotracheal tube (SETT)  
Endotracheal tube designs have led to the incidence of VAP. The design of endotracheal 
tubes, when positioned into the tracheal creates a space that accumulates subglottic secretions 
(American Thoracic Society, 2004). The area where these subglottic secretions pool is where that 
accumulation of fluid provides a great vector for growing bacteria, which then can migrate down 
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the endotracheal tubes. The original design of endotracheal tubes and even tracheostomy tubes is 
considered the cause of VAP (Tablan, Anderson, Besser, Bridges, & Hajjeh, 2003). Any device 
that leads to the buildup of secretions below the vocal cords, secured in place with a cuff that 
holds the airway device in place, is determined the contributing factor for VAP. The area of 
pooled secretions provides a direct path of bacteria into the lungs by way of the endotracheal 
tubes. Current research from Society of Healthcare Epidemiology of America (SHEA), Center 
for Disease Control and Prevention (CDC), and American Thoracic Society recommends SETT 
to reduce subglottic secretions in ventilated patients requiring over 48 to 72 hours of intubation 
(Klompas, 2015). The benefit of reducing subglottic secretions leads to the multidisciplinary 
team approach from clinical experts, with the focus by all is to reduce the environment that 
prevents biofilm growth.  
Multidisciplinary team 
The trauma center’s multidisciplinary team is comprised of trauma surgeons, intensivist 
and emergency medicine doctors, and anesthesiologist to represent the physician component of 
our team. The nursing component is championed by emergency department (ED), operating 
room (OR), and ICU nurses. Department/facility leadership are members to facilitate the 
organizational changes at the macrosystem level. The Infection Control and Quality are at the 
heart of the team. Each clinical expert is a representative of a larger group of professionals to 
work with the multidisciplinary team and hard-wire the utilization of SETT and to improve 
performance on the ventilator bundles. The organizational goal is to reduce subglottic secretions 
and drive VAP to zero.   
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Rationale 
Informational interviews are used to gain a clear understanding of what are the 
contributing factors that cause VAE (Morris et al., 2011). After a series of interviews, the CNL 
develops an Ishikawa diagram displaying the potential causes of a VAE in order to identify its 
root causes (see Appendix B).  The fishbone diagrams are presented to the Prevent VAE Team; 
the team determines that the focus of reducing subglottic secretions is the specific aim for the 
phase I of the project. The fishbone demonstrates the relationships between VAE and reduction 
of subglottic secretions. The priority is to utilize a SETT for intubation greater than 48 hours 
during all ICU admissions (see Appendix B).  
The CNL reviews the VAE quality performance bundles, current facility’s policies, and 
perform daily nursing practice assessments to identify other causes that contribute to the VAE 
events. This is the foundation to prioritize the team plan for action. These findings are 
synthesized into a process flow diagram to facilitate a multidisciplinary team discussion about 
assignment of responsibilities, how the process should be completed, and how the project will 
succeed (see Appendix C).  
Having an understanding of the leadership changes at the organization level provides a 
clear leadership path for the CNL to affect and impact a change of this size. The structure of the 
quality initiative is crucial to develop a culture that will align with the organizational goals to 
eliminate VAE. The adoption of the goal to reduce SETT secretions became evident, as the 
context of each multidisciplinary team members’ anecdotal remarks led to that same intervention 
Identification of the varying aspects that each team represented to decrease subglottic secretions 
became the obvious first phase of the project to reduce VAE (Prevent VAE Team, 2018).    
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PICOT statement 
Patient  
The patients included in the Prevent VAE improvement project are all patients in the ICU 
who require mechanical ventilation for over 48 hours. Trauma patients are the primary focus due 
to the identification of the incidence in the Level II Trauma Centers ACS Report (ACS, 2017).  
Problem 
The problem occurs when the accumulation of subglottic secretions occur. When there is 
not a subglottic suction device present on the endotracheal tube, the ICU patient is more 
susceptible to VAE. Untreated VAE can later result in Ventilator Associated Pneumonia. 
Intervention 
Standardization of the Endotracheal tubes in the ICU that allows subglottic suctioning on 
all ICU admitted patients. Revision of the ICU daily rounding flowsheet is to align with VAE 
prevention bundles and to prevent inconsistency of practice amongst the multidisciplinary team. 
Comparison 
The comparison of patients who develop VAE with those patients who are ventilated and 
do not develop VAE.  
Outcomes 
Consistent reduction of subglottic secretions in all ICU ventilated patients and increase 
multidisciplinary team VAE bundle compliance to prevent VAP.   
Time 
The project consist of two phases. Phase 1: From July 1 to July 31, all ICU ventilated 
patients will prioritize the use of SETT and the team will assure compliance with the VAE 
bundle aimed by the use of the multidisciplinary ICU daily rounding flowsheet (see Appendix 
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D). Phase 2: The facility will evaluate the effectiveness of the SETT and facilitate evaluation of 
the SETT utilization in the prehospital environment (EMS).   
Specific aim 
  The Prevent VAE Team’s aim is to implement evidence-based practice strategies to 
reduce the incidence of VAE. By July 31, 2018, the Level II Trauma Center will revise, 
operationalize, and improve the Prevent VAE teams’ bundle compliance by 20%. This will 
improve performance of the following evidence-based practice guidelines. 
Trauma Surgeons and Intensivists 
• Prioritize utilization of endotracheal tubes with subglottic suctioning (hi-lo tube) to 
clear subglottic space. This will include a ICU assessment for switching to the SETT.  
• Monitor daily VAE bundles for compliance.  
• Orders to maintain the head of bed at 30° to 45° angle unless contraindicated.  
• Provide daily sedation vacation to assess patient readiness to wean off of the 
ventilator.  
• Provide enteral feedings within 48 hours of intubation.   
• Provide peptic ulcer disease treatment.   
• Provide Deep Venous Thrombosis prophylaxis treatment.  
• Daily intensive care rounds held to evaluate progress, implement early goal-directed 
treatment plans, and identify any ventilator associated events.  
Nursing 
• Compliance with VAE bundles for evidence-based care.  
• Perform hand hygiene before and after respiratory care.  
• Prioritize maintenance of SETT.  
IMPROVE EFFECTIVENESS TO REDUCE VAE 13 
• Utilize frequent suctioning, oral care with Chlorhexidine Gluconate twice a day. 
• Communicate progress of spontaneous breathing trial with potential to wean. 
• Facilitate early mobility.   
Respiratory Therapist 
• Maintain VAE bundles of trach cuff pressure of at least 20-centimeter water.   
• Perform hand hygiene before and after any respiratory care.   
• Use disposable ambu-bags that are single patient use only.   
• Use heated wire circuits to provide humidity; do not allow condensation to drain 
backwards. Change circuits only when necessary (14 day cycle or when dirty).  
• Participate in frequent suctioning and maintenance of functioning subglottic suction 
to endotracheal tubes.   
Methods 
Context 
The utilization of a qualitative convergent-care research (CCR) method determines the 
direction and structure of the multidimensional project. The CCR consists of intentional 
solutions to a well-known problem, with the introduction of innovative practice improvement 
initiatives to accomplish a goal (Stevens, 2013). The process improvement project takes place in 
a 34-bed ICU in a Level II Trauma Center. The population consist of ventilated patients in the 
ICU setting during the month of July 2018. The project is to refine the multidisciplinary teams’ 
performance to meet standards of evidence-based care. It was important during the change 
process to preserve the autonomy of the high-functioning multidisciplinary team yet maximize 
the continuity of the team’s performance toward a common goal.   
Ishikawa 
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Analysis of the informational interview process demonstrates the promotion of quality 
bundle compliance, starting with the assurance of the correct endotracheal tube utilization in the 
pre-hospital and OR environments. Both the pre-hospital and the OR areas currently are not 
using the SETT. Consequently, not having the SETT, will predispose the ICU patients to 
accumulate subglottic secretions, which could lead to a VAP.   
The gateway of intubated patients from the pre-hospital setting and the OR are a primary 
focus to set the process improvement on track. It is determined that having the SETT in these 
areas, will improved compliance with preventative VAE measures.  
The informational interviews held by the trauma in the role of a CNL are to analyze 
similarly structured open-ended questions format. The team participation, communication and 
clarification at the multidisciplinary meetings led to the normalization the CNL biases.  
Plan 
The data elements are collected between July 1 and July 30, 2018 in two phases. The first 
phase included a computerized data pull from data directly entered in the electronic health 
record. The development of an integrated database is in use to collect data elements that are 
structured by input from the multidisciplinary team. The Director of Quality creates the database. 
Additional manual data is collected from the ICU daily rounding form (see Appendix D).  
To guarantee reliability, the information from the ICU rounding form is a standardized 
answer picklist, of the most common answers, with limited fill-in capacity. The format is created 
to standardize the approach. The rounding tool’s design meets compliance to the local medical 
center’s critical care team (see Appendix E).  
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Interventions 
The initial step of the Prevent VAE team is to review the current Infection Control policy 
that describes each part of the VAE quality performance bundle. Through informational 
interviews with each discipline’s champions and disruptors alike, their input added into the 
design of a cause and effect analysis (Levasseur, 2001). The Ishikawa diagram demonstrated the 
strengths and weakness for the prevention of VAE. Coordination and teamwork are determined 
to be our process improvement technique. 
 In a meeting on June 6, 2018, the review of the Ishikawa drawing were analyzed by the 
team for input. From there, the team engaged in a deep dive analysis, which unanimously pointed 
the multidisciplinary group in the direction of reducing subglottic secretions. Each discipline is a 
champion of a multifaceted approach to re-engage their team with top performance goals. The 
importance of utilizing a transformational leadership style is to engage the leaders within the 
microsystem, to unfreeze their team’s current behaviors, and to prioritize a re-energizing spirit to 
adopt this change (Levasseur, 2001).  
The members of the Prevent VAE team are challenged with a state of many 
organizational changes, competing priorities and transition of upper leadership. The focus is to 
drive quality initiatives and improve medical center performance as the mission of the 
organization in heading toward a “Highly Reliable Organization” (Beyea, 2012).  
An understanding of the benefit to decrease VAE is to improve patient outcomes as  the 
driving force for the team to be committed to the ventilator bundle compliance. The reduction in 
subglottic secretions is tied to ventilator bundle daily performance. The trauma nurse in the role 
of the CNL demonstrate the clinical expertise and leadership to navigate the multidisciplinary 
team to accomplish these goals.  
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The development of a VAE tracking database is championed with the assistance of the 
Director of Quality (see Appendix E).  The ability to measure and communicate the team’s 
results are key to benchmark progress in the program (AACN, 2017).    
Operating room change process 
One challenge is the introduction of the SETT into the OR. The anesthesia champion 
introduces the SETT process in the OR. Intubation of all patients not to be immediately 
extubated post-operatively will have the newly identified process utilizing the SETT. The change 
in equipment and practice requires education to the OR/anesthesia team. The staff education is 
provided on June 17 and June 19, 2018 by the CNL and the OR educator following the project 
timeline (see Appendix F). This included four sessions of education with the anesthesiologist on 
site. Evidence base articles are provided to reinforce knowledge. The change of SETT takes 
place as plan on July 1, 2018. The anesthesia champion engaged any technique questions and 
managed all performance measure in association with the utilization of the subglottic 
endotracheal tube.  
The adaptation to placing the subglottic endotracheal tube is consider minor to address 
placement technique. The suggestions for managing the secondary pigtail associated with the 
subglottic suction are explained for optimal endotracheal tube placement (see Appendix G). The 
OR RN staff are educated on the elements to address connecting the subglottic suction to low 
intermittent suction and reassessment during the case to ensure functioning status and no 
clogging from thick secretions. Live demonstration, plus hands-on return demonstrations are 
utilized to instruct the OR team. 
The population of traumatic brain injury patients and trauma patients in extremus are 
determined to achieve the most benefit from early placement and evacuation of subglottic 
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secretions. On analysis of pre-implementation data, these two cohorts of patients had the highest 
incidence of VAE. The initial injury pattern was determined to play a factor in incidental 
aspiration at the time of injury/event. Stroke, as well as trauma patients, fell into a similar cohort 
of high incidence for VAE, who will benefit from prevention strategies.   
Subglottic Endotracheal Tube Equipment 
The proper equipment availability is an important factor to the success of the OR 
transition to SETT usage and for all in-hospital intubated patients. The endotracheal tube is 
standardized in all areas of the medical center, excluding the OR. The in-depth microsystem 
assessment involved working with the OR team, including the anesthesia technician, to evaluate 
a convenient location to store the subglottic endotracheal tubes for ease in accessibility. Order 
information is obtained from the respiratory department leader, and a process is developed to 
update the OR ordering form, plus reorganization of the anesthesiologists’ carts to have the 
SETT readily available. 
 All other intubation trays had the SETT as a standard. The intubation tray stocking is 
managed by the respiratory therapy department, and they collaborate with OR to facilitate this 
long-awaited change in practice. Lewin’s unfreezing process is part of the integration of 
evidence-based support to engage the OR team to collaborate in the key aspect of adopting the 
use of the SETT (see Appendix G) (Levasseur, 2001). 
Model for Improvement 
The model for improvement (MFI) is followed for improving the performance with the 
ventilator prevention bundles and the focus is to decrease subglottic endotracheal tube secretions. 
The MFI is used to implement small tests of change (Nuckton, Holko, McKay, & Newman, 
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2006). Team STEPPS briefing and debriefing was the concept used to support the team’s efforts 
to hardwire successive change measures to accomplish a unified goal to reduce VAE to zero.  
The first month of this process improvement project is to decrease the subglottic 
secretions. The second phase of the project is to introduce early mobilization into the medical 
center plan plus integrate the pre-hospital evaluation and training into the equation for success 
with VAE reduction. By analyzing the hurdles that are faced by the trauma/medical teams, the 
team designed the first phase role out of the project. 
Change Strategy 
The change strategy of Lewin’s unfreezing previous behaviors is changing to new 
subglottic endotracheal tubes and refreezing the improved teamwork and performance strategies 
to reduce VAE by 10% within the next month and is the goal of the first phase of the project 
(Schriner et al., 2010). The team will focus on ensuring all endotracheal tubes utilize the 
subglottic suction to its fullest performance. The nurses’ focus will be on consistent oral care and 
daily spontaneous breathing trials, in partnership with respiratory therapy and team 
communication on the updated ICU daily rounding flowsheet to navigate and benchmark the 
multidisciplinary team’s performance.   
Multidisciplinary Team Roles  
The interdisciplinary team supervisor/director will be responsible for orienting new staff 
to the VAE reduction focus as part of new hire orientation at the Level II Trauma Center. The 
unit-specific champions will be responsible for onsite reinforcement for continued success of the 
project. Huddles will be used to focus priorities of the team communication and progress. 
Communication is the key element. The TeamSTEPPS briefing strategy will be utilized to 
provide strategic information to the units for benchmarking progress and motivation for team 
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effort to support improved VAE prevention bundle compliance (Betts & Healy, 2015).  Utilizing 
the briefing strategy will reinforce the important information. Debriefing will be initiated by the 
trauma PI CNL, department leadership, and unit-based champions to drive this process 24 hours 
a day, seven days a week, 365 days a year. The communication will focus on engaging the 
support of the patient care staff for interactive questions and answers to support the teamwork. 
Data 
A benchmarking strategic plan will include monthly data distributed on a HACs 
dashboard to the ED, OR, and ICU. The data will be compiled from a joint effort of the trauma 
database and electronic medical record. An Access database, designed by the medical center’s 
director of quality, will be used to demonstrate strategic performance. The complex data analysis 
includes monitoring between multiple ventilator days and complex team performance. Analysis 
of the process to incorporate all the data elements is essential for the team’s improvement and 
benchmarking strength to drive individual, as well as team, performance. The structured database 
is designed for growth with each phase of the improvement process. Phase II will include early 
mobility metrics, in addition to emergency medical services’ use of subglottic endotracheal tube 
placement, to trend improvement and success.   
Initial Phase 
The initial phase of this two-part project to reduce VAE will be completed by August 
2018. Ongoing re-evaluation will be checked each month for the remaining part of 2018. Once 
the VAE performance bundle change is stabilized, the re-evaluation plan will be quarterly and 
progress reported to the trauma/medical quality review and operation team meetings.   
Change Model 
The initial step of the Prevent VAE team was to review the current infection control 
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policy that describes each part of the quality performance bundle. Through informational 
interviews with each discipline’s champions and traditionalist (Stevens, 2013), we designed a 
cause and effect analysis of strengths and weakness for our ventilator bundles. Coordination and 
teamwork of forming, storming, norming, and performing was determined to be our research 
technique (Betts and Healy, 2015). In a meeting on June 6, 2018, we reviewed the Ischikawa 
drawing of the team’s input. From there, we engaged in a deep dive analysis, which unanimously 
pointed the multidisciplinary team in the direction of reducing subglottic secretions. Each 
discipline championed a three-pronged approach to re-engage their team with top performance 
goals. Transformational leadership engaged the microsystem to unfreeze the current behavior to 
prioritize an improvement culture. The importance of the trauma PI CNL to utilize a 
transformational leadership style to engage each of the VAE disciplinary leaders was the 
important skill to unfreeze the current behaviors. Reprioritization and re-energizing the spirit to 
adopt the Prevent VAE change was the initial goal. This is an important problem, with the goal 
of improving outcomes for the ventilated ICU patients. The members of the Prevent VAE 
multidisciplinary team were challenged with many competing priorities within the organization, 
in addition to a change in leadership. The focus was to drive quality initiatives and improve 
medical center performance, so this was a common goal for the ICU department, the trauma 
department, and the macro system (Viana, Bragazzi, Couto de Castro, Alves, & Rocco, 2013).  
The clear understanding of complexities plus multivariate factors with each ventilated patient 
was the multidisciplinary team’s motivation to drive their initiative in a competitive spirit (Viana 
et al., 2013). Understanding the benefit of decreasing VAEs and improving patient outcomes led 
to the team’s commitment to the ventilator bundle compliance of decreasing subglottic 
secretions. The trauma process improvement RN, working as a clinical expert and leader, and 
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navigated the multidisciplinary team and developed a database, with the assistance of the quality 
liaison director, to measure and communicate the team’s results.    
Lewin’s Change Strategy  
One challenge is the introduction of the subglottic endotracheal tube into the OR. The OR 
staff are very structured and rigid to new changes creating a more traditionalist view of change 
(Schriner et al., 2010). The subglottic endotracheal tube introduction will bring new challenges 
for the team. The anesthesia champion introduced the change in process to intubate all patients 
that will not be immediately extubated post-op with the subglottic endotracheal tube. The change 
in equipment and practice required education for the OR/anesthesia team. On June 7, the OR was 
educated by the trauma PI CNL and the OR educator. This included four sessions of education 
that included the anesthesiologist on site. A plan for the change to be initiated July 1, 2018, with 
evidence-based literature articles, was sent the anesthesia team. The anesthesia champion 
engaged any technique questions and managed all performance measure in association to the 
utilization of the subglottic endotracheal tube. The adaptation to placing the subglottic 
endotracheal tube is considered minor in addressing placement technique with suggestions for 
managing the secondary pigtail associated with the subglottic endotracheal tube. The OR RN 
staff was educated on the elements to address connecting the subglottic suction to low 
intermittent suction and reassessment during the case to ensure functioning status and no 
clogging from thick secretions. 
Population 
The population of traumatic brain injury patients and trauma patients in extremus were 
determined to achieve the most benefit from early placement and evacuation of subglottic 
secretions. On analysis of pre-implementation data, these two cohorts of patients had the highest 
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incidence of VAE. The initial injury pattern was determined to play a factor in incidental 
aspiration at the time of injury/event. Stroke patients, as well, fell into a similar cohort of high 
incidence for VAE prevention strategies.   
This equipment availability is an important factor to the success of the transition to 
subglottic endotracheal tube usage for all in hospital-intubated patients. The endotracheal tube is 
standardized in all areas, excluding the OR. The in-depth microsystem assessment involved 
working with the OR team, including the anesthesia technician, to evaluate a convenient location 
to store the subglottic endotracheal tube for ease in accessibility. Order information was obtained 
from the respiratory department leader and a process developed to update the OR ordering form 
and reorganize the anesthesiologist’s carts to have the subglottic endotracheal tube readily 
available. All other intubation trays had the subglottic endotracheal tubes as a standard. The 
respiratory therapy department manages the intubation tray stocking, and they collaborate with 
OR to facilitate this long-awaited change in practice.  
TeamSTEPPS 
The MFI was the strategy followed for improving performance with the ventilator 
prevention bundles and the focus to decrease subglottic endotracheal tube secretions. The MFI 
will be used to implement small tests of change (Nuckton et al., 2006). Team STEPPS briefing 
and debriefing will be used to support the team’s efforts to hardwire successive change measures 
to accomplish a unified goal to reduce ventilator associated events to zero. The first month of 
this process improvement project was to decrease the subglottic secretions. The second phase of 
the project is to introduce early mobilization into the equation for success with VAE reduction.  
After analyzing the hurdles faced by the trauma/medical teams, we designed the first phase role 
out of the project. 
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Change Strategy 
The change strategy of Lewin’s unfreezing previous behaviors and refreezing the 
improved teamwork and performance strategies to reduce VAE by 10% in the following month 
(Schriner et al., 2010). The team will focus on ensuring all endotracheal tubes utilize the 
subglottic suction to its fullest performance. The nurses will focus on consistent oral care, daily 
spontaneous breathing trials in partnership with respiratory therapy, and team communication on 
the updated ICU daily rounding flowsheet to navigate and benchmark the multidisciplinary 
team’s performance.   
Multidisciplinary Team Roles 
The multidisciplinary team supervisor/director will be responsible for orienting new staff 
to the VAE reduction project as part of new hire orientation at the Level II Trauma Center. The 
unit-specific champions will be responsible for onsite reinforcement for continued success of the 
project. Huddles is used to focus priorities of the team communication and progress. The 
TeamSTEPPS briefing strategy is utilized to provide strategic information to the units for 
benchmarking progress and motivation for team effort to support improved VAE prevention 
bundle compliance. Utilizing the briefing strategy will reinforce the important information 
(Tibbs & Moss, 2014). Debriefing will be initiated by the trauma CNL, department leadership, 
and unit-based champions to drive this process, 24 hours a day, seven days a week, and 365 days 
a year. Communication will focus on engaging the support of the patient care staff for interactive 
questions and answers and to support the teamwork. 
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Benchmark 
A benchmarking strategic plan will include monthly data distributed on a HAC dashboard 
to each corresponding department team. The data is compiled from a joint effort of the trauma 
database and the electronic health record. An Access database provides additional information 
and is designed by the facility Director of Quality to demonstrate strategic performance.  
The complex data analysis includes monitoring between multiple ventilator days and 
complex team performance.  Analysis of the process to incorporate all the data elements is 
essential for the team’s improvement and benchmarking strength to drive individual 
performance, as well as team performance. The structured database is designed for growth with 
each phase of the improvement process. Phase II will include early mobility metrics to trend for 
improvement and success.    
The initial phase of this two-part project to reduce VAE is to be completed by August 
2018 (Appendix F). Ongoing re-evaluation will be checked each month for the remainder of 
2018. Once the VAE performance bundle change is stabilized, the re-evaluation plan will be 
quarterly and the progress is reported to the trauma/medical quality review and operation team 
meetings.   
Study of the Intervention 
The intervention strategy that the Prevent VAE team agreed to use is to improve 
performance on the VAE bundle compliance. A bundle is a structured way of improving the 
processes of care and patient outcomes—a small, straightforward set of evidence-based practices 
(Nuckton et al., 2006). The Prevent VAE team realizes that evaluating and improving team 
performance on the evidence-based practice guidelines is the foundation of the ICU Prevent 
VAE’s improvement project. The Prevent VAE team analyzed their respective team’s consistent 
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performance of the prevention bundles and realized that key opportunities to provide consistent 
bundle delivery are the foundation of the project. The data analysis from retrospective chart 
review brought new perspective to system issues that prevented optimal performance for VAE 
prevention bundle compliance. The Prevent VAE team identifies that the ICU rounding tool is an 
ideal structure to communicate and trend the required data elements for the aim to zero ventilator 
compliance strategy. Teamwork is the focus of the daily multidisciplinary rounding, and the tool 
is a useful way to share on-time information, adjust performance, and drive success for VAE 
prevention. The Prevent VAE ‘s champions revised the ICU rounding form to add key elements 
to track subglottic endotracheal tube usage. The ability to provide real-time feedback to 
anesthesia for prioritizing subglottic endotracheal tube utilization for patients who would require 
ongoing intubation in the ICU setting is valuable for debriefing about any variance in the 
process. The real-time feedback allows debriefing and planning to look at any variation in 
process. The trauma surgeons/intensivist that lead the ICU rounds provides the opportunity to 
drive the SETT exchange as a patient is stabilized. The standard endotracheal tubes are 
prioritized to be exchanged for SETT at this time. The daily goal of decreasing subglottic 
secretions, plus VAE prevention progress, are tracked and reinforced by the VAE champions to 
increase compliance with decreasing subglottic secretions. 
Cohort Comparison 
Cohort comparison case review led the team to determine that SETT introduction into the 
OR setting is heading in the direction to integrate the process of decreasing subglottic secretions. 
The new OR director joined the Prevent VAE team in progress of implementation. The 
anesthesiologist placement of the SETT is similar enough to the standard endotracheal tube 
placement so there is not a need for additional training (see Appendix G). Although this is the 
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overall pre-implementation thought process, the anesthesia team is supported by the anesthesia 
director, for performance evaluation and support for education. The team support is to place the 
subglottic endotracheal tubes for those patients requiring ongoing intubation into the ICU setting. 
The anesthesia director and the OR educator partnered with real-time feedback to those cases 
identified by the trauma CNL in the role of risk anticipator, to position the team for success by 
reinforcing the Prevent VAE team’s strategic goals (AACN, 2017).   
Operating Room Change   
The OR is an extremely important area identified by the team for standardizing the use of 
SETT throughout the medical center. All other medical areas, including ED, ICU, rapid response 
team (RRT), and code carts, are stocked with only SETT. This identified area for process 
improvement is managed by the coordination of the Prevent VAE team’s ability to share 
evidence-based practice information. The supporting studies from CDC, SHEA, and American 
Thoracic Society are used to unfreeze the traditionalists and create the awareness for 
disseminating information (Levasseur, 2001). The focus is designed to support the awareness 
required to motivate the change process. The OR integration is the first strategic step toward 
Level II Trauma Center endotracheal tube standardization to attack subglottic secretions. 
Pre-Hospital Evaluation 
Case review inquiry led the Prevent VAE team to analyze the organization for other ports 
of entry for standard endotracheal tubes. The identification of this fact led to the practice of 
standard endotracheal tubes being placed in the pre-hospital setting as the next phase on our 
mission to reduce subglottic secretions in ventilated patients. The field represents the area where 
injury patterns of decreased neurological status, proven from trauma, stroke, or shock, 
predisposed those patient populations for incidental aspiration. In order to manage the secretions 
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trapped in the trachea, the SETT is the ideal solution to combat the problem. Phase II of the 
Prevent VAE project includes the EMS providers’ medical director, to perform a subglottic 
endotracheal tube evaluation. The SETT representative is in contact, and the initial educational 
process is scheduled in August 2018 for introduction of the new product into the EMS provider 
system. The trauma CNL will analyze data from trauma case review to drive process 
improvement change throughout the trauma mesosystem.   Continuous trauma case review and 
process improvement will be driven by the ACS initiative to support evidence-based care 
nationwide. 
Measures 
Both quantitative and qualitative measures are in use to analyze data to evaluate the 
Prevent VAE measures, with the aim for zero improvement project. The data extracted will be 
derived from patient cohort identification, admission diagnosis, medical history, calculations of 
ventilator days and titration of ventilator settings of FIO2 and PEEP, type of endotracheal tube, 
percent of functioning subglottic suction, percent of oral care, and number of bronchoscopies in 
relation to the outcome measures of number of VAE to ventilated patients for the month of July 
2018 (see Appendix E). During the month of July, there are three VAE for 48 ventilated patients.  
There are 39 SETT in ICU versus seven standard endotracheal tubes.  There are 98.7% of the 
ESTT originated from the ED. The ED has been utilizing SETT for the past two years. More data 
will need to be attained to determine the success in the OR integration of the SETT. There are 
three endotracheal tubes placed in the pre-hospital setting and two in the OR. The use of SETT is 
the main element being evaluated in the Prevent VAE improvement process. Although the team 
does not see many originating from the OR, eight patients is transferred from ED to the OR 
already intubated. The data shows that only three VAE occurs in July, with one patient having 
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two episodes of VAE. This marks the progress of Phase I of the Prevent VAE project. No trauma 
patients with VAE for the past two months are identified. 
Quantitative measures include the number of SETT used in comparison to the routine 
endotracheal tube during July. The 98.7% utilization of SETT is attributed to the decrease in 
incidence of VAE. Each month, the number of SETT are tracked in order to hardwire the 
progress of the Prevent VAE team. The data analysis and communication will be used to guide 
the aim of the project to reduce VAE to zero by December of 2019. The trauma center locations 
where endotracheal tubes are placed will be tracked to delineate future Prevent VAE project 
phasing. This factor is identified from the results of Phase I analysis and leads to the Phase II 
pre-hospital subglottic endotracheal tube evaluation. 
The qualitative evaluation of the cohort case reviews, and the data from the ICU daily 
rounding flowsheet, are what attributes VAE prevention bundle effectiveness that are used to 
decrease subglottic secretions; as the means of data. The qualitative tool used to evaluate the 
progress of the multidisciplinary Prevent VAE team’s ability to meet their goal still requires 
some improvement.  The ability to increase the Prevent VAE bundle compliance is directly tied 
to the reduction in subglottic secretions by the functioning of the subglottic suction system, oral 
care bundles, and increased mobility; this information is difficult to track.  
The effectiveness of ICU rounding, which has VAE performance measures integrated 
into them, provides improved team coordination of information for real-time continuous quality 
improvement (Nuckton et al., 2006). The ICU tool is in revision again to add additional ICU 
elements into the daily rounds. The increased awareness of the improvement project with the 
daily rounding helped maintain the Prevent VAE team’s goals, despite the pitfalls of the tool. The 
team identified that there is a need to have a new rollout plan as the project moves forward.   
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Shared Initiative  
The development of the Access database to compile the VAE results is a shared 
organization initiative to integrate the trauma improvement team, collaborating with the quality 
department, to drive mesosystem change. VAE is a reportable quality metric and an ACS focus 
to integrate performance measures across the continuum of the entire mesosytem (ACS, 2017). 
The multidisciplinary Prevent VAE team provides the Level II Trauma Center a beneficial forum 
to achieve quality success and improve patient outcomes. Although a majority of the ESTT are 
placed in the ED, utilizing it demonstrates the reduction in VAE during the month of July.  
Ethical Consideration 
Patient advocacy to protect the vulnerable is the number one ethical consideration for the 
Prevent VAE team. Advocacy is the CNL role that is at the center of all considerations for the 
multidisciplinary team. From the physiological requirement for ventilator support to the 
endotracheal tube exchange, the clinical decisions for the patient involve the analysis for risk and 
improved patient outcomes. Timing to predict when benefit will outweigh risk is attributed to 
every medical provider’s decision to exchange an endotracheal tube. Physiological stability is 
always the qualitative measure to clearly make the endotracheal tube exchange decision.   
Autonomy 
Support for autonomy is an ongoing requirement for evaluating ventilator support in 
consideration to improve patient outcomes. When the patient is unable to actively participate or 
communicate their wishes, the family is able to follow what the patient has previously decided 
for themselves (Mehndiratta et al., 2016).  
Through the multidisciplinary Prevent VAE team’s evaluation, the decision to add early 
mobility into the VAE bundle compliance is unanimously determined as the next phase of the 
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process improvement. The culture for engaging frontline staff into continuous quality 
improvement is infectious in a positive nature. The autonomy and strength to incorporate 
ambulation inspires benefit to patients, their families, the entire multidisciplinary team, and the 
whole culture of the microsystem (Mendez-Tellez & Needham, 2012).     
Outcome Measures Results 
The effect that the implementation of decreasing subglottic secretions by implementing 
ICU daily rounding flowsheet to coordinate VAE prevention bundle compliance attributes 
qualitative measures to review the process improvement results. The trauma CNL reviews and 
analyzes all qualitative data. The standardization of clinical definitions are attribute by the CDC 
definitions for VAP. Variation of clinical biases is controlled by navigating fill-in responses to 
the most common information available from chart review prior to program implementation.   
Database 
The Access database developed by the quality director integrated computerized generated 
input directly from the electronic health record. The ability to present clear data is strength of the 
Prevent VAE team’s benchmarking abilities. The collaboration of the quality department and 
trauma to work together to achieve a reduction in the most costly HAC in the organization 
demonstrated a new partnership for the organization.  
Analysis 
Prevent VAE project analysis demonstrated a 98.7% utilization of SETT in July 2018. 
The 39 SETT per 46 ventilated patients attributed to the number of SETT used in the ICU. There 
are no endotracheal tubes exchanged by the intensivists in the ICU for the month of July 2018. 
Reinforcement for the Prevent VAE project’s goal is to utilize SETT for ventilated patients over 
48 hours was 80% for the month of July. The team will need to continue to educate and reinforce 
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the utilization of SETT.  
Summary 
By instituting the use of SETT in the OR, the facility standardize endotracheal tubes 
and work as the foundational process to decrease subglottic secretions as the vector that 
contributes to VAE at the Level II Trauma Center. The goal of a 10% reduction is 
achieved during Phase I of the project. The addition of incorporating the progress of the 
multidisciplinary team to attack the problem of VAE and improve quality bundle 
performance compliance is the largest contributing factor for the process improvement.  
The cost of a the subglottic endotracheal tube is $3.00 more than the standard endotracheal 
tube. The cost of one VAE is conservatively estimated to be $21,500 per diagnosis 
(Charge master, 2017). On average, each VAE demonstrates a 1.5 to 9 day increase in 
length-of-stay in the ICU (Bekaert et al., 2011). The Prevent VAE team designed a 
practical approach to reducing VAE. The Prevent VAE team’s clinical expertise 
motivated the compliance of the frontline staff to guide the successes. The integration of 
the ICU rounding tool into delineating team progress and navigation is strategic to the 
improvement process. The ICU multidisciplinary rounding will be integral to the Prevent 
VAE communication and adaptation. Variations in practice can be identified and either 
corrected or adopted to evaluate for future best practice evaluation.   
The Prevent VAE team learned that they could improve team performance more quickly 
working together on the same goal versus independently to achieve a common goal. Teamwork 
was the unifying structure that resonated the success of the aim to drive VAE to zero. The depth 
of clinical expertise in the multidisciplinary team and in the leadership in daily ICU rounding 
empowered the frontline staff to own and share in the pride of the performance on the Prevent 
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VAE clinical performance bundles to achieve improved outcomes for the ICU patients and their 
families. 
The Prevent VAE team interpreted the OR change as a success at the mesosystem level.  
Identification of the EMS recommendation to utilize subglottic endotracheal tubes for all 
emergent intubations will present a new phase to continue the opportunity to decrease VAE, and 
plans to pursue the county evaluations. Analysis of this study is a contributing factor to 
demonstrate that utilization of SETT and teamwork to clear subglottic secretions as the best 
practice standard. This process requires further evaluation throughout the county system for 
possible adoption nationwide.  
Limitations 
The Prevent VAE team’s limitations are a multitude of competing clinical priorities. In 
analysis of the clinical data, the Prevent VAE team evaluated the patient acuity and timing of 
consistent oral care. The hurdles of team compliance factors attributed to the availability of 
supplies is addressed by increasing oral care kits in the ICU, especially on weekends and 
holidays.  Noted variation is attributed to the factor of accessibility of oral care with 
chlorhexidine.  Consistency in the bundle compliance of oral care is focused as part of the bundle 
compliance for nursing. Suction regulator accessibility in the OR and the ICU became a factor of 
increased utilization of SETT. Department leadership identified a standard room set-up that 
included an additional suction regulator for SETT suction.  Teamwork with frontline staff and 
department leadership attributed to the success of this on-going priority for consistent successful 
bundle compliance. Sustainability will be supported by evaluation at the ICU/trauma Quality 
Review (QRC) Committee meetings. Plans for the Prevent VAE team’s ongoing needs will be 
prioritized at the QRC meetings, and ongoing loop closure measures will be placed into the 
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department performance dashboards.  
Conclusion 
In order to achieve the goal of driving VAE to zero in the ICU at the Level II Trauma 
Center, the development of a multidisciplinary Prevent VAE team is created. The combination of 
clinical expertise and champion mentoring, real-time debriefing, and coordination of progress 
with the daily ICU rounding supported the multidisciplinary team bundle compliance to reduce 
VAE (Tibbs & Moss, 2014). The implementation of this project is reproducible. Evidence-based 
bundle compliance is the standard of care. Transparency in the hurdles to optimal 
multidisciplinary team performance led the required system changes to support the bundle 
compliance.  Teamwork with the response to the identified common goal to reduce VAE is 
integral to adoption and project success. Integration of the ICU rounding tool to navigate the 
project progress and to continue the support, is attributed to the success to reduce VAE at the 
Level II Trauma Center.  The ICU team leadership includes intensivist, trauma, OR, nursing, and 
respiratory peer champions, who all collaborate to engage the staff with real-time support. The 
implications for practice are in utilizing the MFI change theory, with small test of change to 
allow the Prevent VAE project to adapt in real time to support the improved patient outcomes.  
Clinical Nurse Leader Role 
In the position of the trauma process improvement CNL, the role of continuous quality 
improvement is the expectation for the role. Trauma patients are assessed and data analyzed from 
the trauma database (CDM, 2018). The role of the CNL is to integrate systems level change from 
the point of care (AACN, 2017). The role is integrated into each phase of the improvement 
process. The CNL, as a leader, works as a horizontal member of the multidisciplinary team to 
coordinate systems level change and improve patient outcomes.   Utilizing Tuckman’s 
IMPROVE EFFECTIVENESS TO REDUCE VAE 34 
teambuilding strategies, the CNL utilized data to encourage team participation and call to action 
to conquer the clinical problem of the HAC VAE. 
IMPROVE EFFECTIVENESS TO REDUCE VAE 35 
References 
Adair, C. G., Gorman, S. P., Feron, B. M., Byers, M., Jones, D. S., Goldsmith, C. E., … 
Milligan, K. R. (1999). Implications of endotracheal tube biofilm for ventilator-
associated pneumonia. Intensive Care Medicine, 25(10), 1072-1076. 
doi:10.1007/s001340051014  
American Association of Colleges of Nursing. (2017). AACN releases new recommended CNL 
practice experiences. Journal of Professional Nursing, 33(4), 260. 
doi:10.1016/j.profnurs.2017.06.009  
American College of Surgeons. (2017). Report ACS verification 2017: Prevent ventilator 
associated events (Internal document: Information presented at employee team meeting).   
American Thoracic Society, & Infectious Diseases Society of America. (2004). Guidelines for 
the management of adults with hospital-acquired, ventilator-associated, and healthcare-
associated pneumonia. American Journal of Respiratory and Critical Care Medicine, 
171, 388-416. doi:10.1164/rccm.200405-644ST  
Bekaert, M., Timsit, J. F., Vansteelandt S., Depuydt, P., Vesin, A., Garrouste-Orgeas, M., … 
Benoit, D. (2011). Attributable mortality of ventilator-associated pneumonia: A 
reappraisal using causal analysis. American Journal of Respiratory and Critical Care 
Medicine, 184(10), 1133-1139. doi:10.1164/rccm.201105-0867oc  
Betts, S., & Healy, W. (2015). Having a ball catching on to teamwork: An experiential learning 
approach to teaching the phases of group development. Academy of Educational 
Leadership Journal, 19(2), 1-9. 
 
 
IMPROVE EFFECTIVENESS TO REDUCE VAE 36 
Beyea, S. C. (2005). High reliability theory and organizations. AORN Journal, 81(6), 1319-1322 
Cason, C. L., Tyner, T., Saunders, S., & Broome, L. (2007). Nurses’ implementation of 
guidelines for ventilator-associated pneumonia from the Centers for Disease Control and 
Prevention. American Journal of Critical Care, 16(1), 28-37. Retrieved from 
http://ajcc.aacnjournals.org/content/16/1/28.full  
Centers for Disease Control and Prevention.  (2018). Device-associated Module-VAE.  In 
National Healthcare Safety Network (NHSN) patient safety component manual (Chapter 
10).  Retrieved from https://www.cdc.gov/nhsn/pdfs/pscmanual/10-vae_final.pdf 
Internal document American College of Surgeons (ACS). (2017). Unpublished internal 
document. 
Internal document Charge Master. (2017). Unpublished internal document. 
Internal document Clinical Data Management (CDM) database. (2018). Unpublished internal 
document. 
Internal document Trauma Quality Improvement Process (TQIP). (2018). Unpublished internal 
document. 
Internal document Prevent Ventilator Associated Events:  Prevent VAE Team. (2018). 
Unpublished internal document. 
Klompas, M. (2015). Potential strategies to prevent ventilator-associated events. American 
Journal of Respiratory and Critical Care Medicine, 192(12), 1420-1430. 
doi:10.1164/rccm.201506-1161CI  
Klompas, M., Branson, R., Eichenwald, E. C., Greene, L. R., Howell, M. D., Lee, G., … 
Berenholtz, S. M. (2014). Strategies to prevent ventilator-associated pneumonia in acute 
care hospitals: 2014 update. Infection Control & Hospital Epidemiology, 35(8), 915-936. 
IMPROVE EFFECTIVENESS TO REDUCE VAE 37 
doi:10.1086/677144  
Levasseur, R. E. (2001). People skills: Change management tools—Lewin's change model. 
Interfaces, 31(4), 71-73. Retrieved from 
http://www.mindfirepress.com/uploads/Lewin_s_change_model_INTERFACES_2001.p
df  
Mehndiratta, M. M., Nayak, R., Ali, S., Sharma, A., & Gulati, N. S. (2016). Ventilators in ICU: 
A boon or burden. Annals of Indian Academy of Neurology, 19(1), 69-73. 
doi:10.4103/0972-2327.167706  
Mendez-Tellez, P. A., & Needham, D. M. (2012). Early physical rehabilitation in the ICU and 
ventilator liberation. Respiratory Care, 57(10), 1663-1669. doi:10.4187/respcare.01931  
Morris, A. C., Hay, A. W., Swann, D. G., Everingham, K., McCulloch, C., McNulty, J., … 
Walsh, T. (2011). Reducing ventilator-associated pneumonia in intensive care: Impact of 
implementing a care bundle. Critical Care Medicine, 39(10), 2218-2224. 
doi:10.1097/CCM.0b013e3182227d52  
Muscedere J., Rewa, O., McKechnie, K., Jiang, X., Laporta, D., & Heyland, D. K. (2011). 
Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: A 
systematic review and meta-analysis. Critical Care Medicine, 39(8), 1985-1991. 
doi:10.1097/CCM.0b013e318218a4d9  
National Health Safety Network. (2017). Retrieved from: Basics of Infection Prevention. 
Nuckton, T. J., Holko, B. H., McKay, S. A., & Newman, J. M. (2006). The Institute for 
Healthcare Improvement ventilator bundle: Definitions, summary, and brief review of the 
evidence. Journal of Organ Dysfunction, 2(1), 48-52. doi:10.1080/17471060500462542  
Schriner, C., Deckelman, S., Kubat, M. A., Lenkay, J., Nims, L., & Sullivan, D. (2010). 
IMPROVE EFFECTIVENESS TO REDUCE VAE 38 
Collaboration of nursing faculty and college administration in creating organizational 
change. Nursing Education Perspectives, 31(6), 381-386.  
Stevens, K. R. (2013). The impact of evidence-based practice in nursing and the next big ideas. 
Online Journal of Issues in Nursing, 18(2). doi:10.3912/OJIN.Vol18No02Man04  
Tablan, O. C, Anderson, L. J., Besser, R., Bridges, C., & Hajjeh, R. (2004, March 26). 
Guidelines for preventing healthcare-associated pneumonia, 2003. MMWR 
Recommendations and Reports, 53(RR03), 1-36. Retrieved from 
https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5303a1.htm  
Tibbs, S. M., & Moss, J. (2014). Promoting teamwork and surgical optimization: combining 
TeamSTEPPS with a specialty team protocol. AORN Journal, 100(5), 477-488. 
doi:10.1016/j.aorn.2014.01.028 
Viana, W. N., Bragazzi, C., Couto de Castro, J. E., Alves, M. B., & Rocco, J. R. (2013). 
Ventilator-associated pneumonia prevention by education and two combined bedside 
strategies. International Journal for Quality in Health Care, 25(3), 308-313. 
doi:10.1093/intqhc/mzt025  
Vincent, J-L. (Ed.). (2012). Annual update in intensive care and emergency medicine 2012. New 
York, NY: Springer 
IMPROVE EFFECTIVENESS TO REDUCE VAE 39 
Appendix A 
Ventilator-Associated Events (VAE) Surveillance Algorithm 
 
Note: Retrieved from CDC Algorithm for Ventilator – Associated Events, January 2018.
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Appendix B 
Ishikawa Diagrams VAE Prevention: Cause & Effect Global Factors 
  
Ishikawa Diagrams VAE Prevention: Cause & Effect Specific AIM
 
Note: Multidimensional factors identified for Prevent VAE Team prioritization to 
decrease incidence of subglottic secretions 
 
Created by Ginger Miramontes June, 2018 
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Appendix C 




Note: Created by Ginger Miramontes RN-Trauma Process Improvement (PI) 
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Appendix D 
Daily ICU Rounding Tool 
 
 
Note:  Briefing tool integrating VAE tracking elements by Ginger Miramontes RN 
Trauma Process Improvement (PI)  
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Appendix E 




















Note:  Screen shots of new database.  Developed for project specific data collection and analysis. 
Data retrieved from Regional Medical Center of San Jose facility’s Quality Department Created 
by Director of Quality Services to support the Prevent VAE Team on July 31, 2018. 
 
 




Prevent VAE Timeline 
 
Note: Timeline for Prevent VAE Improvement Project Phase I  
 
Created by Ginger Miramontes RN 
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Appendix G 






Note:  Adapted from (Muscedere, 2011) Rational for Utilization of Subglottic ETT to clear 
subglottic secretions 
IMPROVE EFFECTIVENESS TO REDUCE VAE 46 
 
Appendix H 









Data retrieved from Regional Medical Center of San Jose facility’s Quality Department Created 
by Director of Quality Services to support the Prevent VAE Team on July 31, 2018. 
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Appendix I 






Data retrieved from Regional Medical Center of San Jose facility’s Quality Department Created 
by Director of Quality Services to support the Prevent VAE Team on July 31, 2018. 
